Moderna Profit Margin 2017-2021 | MRNA
Current and historical gross margin, operating margin and net profit margin for Moderna (MRNA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Moderna net profit margin as of June 30, 2021 is 49.79%.
|Moderna Annual Profit Margins
|Moderna Quarterly Profit Margins
||Medical - Biomedical and Genetics
Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA- 2752 for Relapsed/Refractory solid tumors malignancies. Moderna Inc. is based in Cambridge, United States.